- My Alerts
- Go Ad-Free
-
My Account
Dilip Shanghvi
Dilip Shanghvi (born November 1, 1955) is an Indian billionaire entrepreneur and the founder and managing director of Sun Pharmaceutical Industries Ltd, India’s largest pharmaceutical company. He is
...Read more- Sun Pharma, Taro terminate merger deal
Taro Pharmaceutical and Sun Pharma have mutually agreed to terminate their merger agreement, announced in August 2012, reports CNBC-TV18's Archana Shukla.
- Indian pharma cos welcome 'outsiders' to up global presence
Last few months saw some high profile changes in the managements of Indian pharma companies. Entirely promoter-controlled companies giving way to professional managements brought in from top multinationals to drive global ambitions, reports CNBC-TV18's Archana Shukla.
- Dilip Shanghvi: Replicating Sun Pharma magic in start-ups!
Sun Pharma is in the pink of health and Dilip Shanghvi now wants to repeat the miracle he performed in making Sun Pharma a billion dollar drug maker, with a host of smaller drug companies, reports CNBC-TV18's Archana Shukla.
- Sun's merger plans: Taro's shareholders may play spoilsport
The Sun Pharma stock rallied 3% today after the drug-maker offered to acquire 100% in the Israeli drug-firm Taro Pharma in which it has 66% stake. While the move got a thumbs-up from analysts, some of Taro’s large shareholders may play spoilsport, reports CNBC-TV18's Archana Shukla.
- With Sun Pharma-Merck striking JV, why is SPARC shining?
According to CNBC-TV18's research analyst Ekta Batra it's SPARC which has emerged as the winner from this deal between Sun Pharma and Merck. They are targeting a portfolio of around 12 drugs in around 100 countries but the focus is expected to be the top 10 countries which are expected to contribute around 80% of revenues.
